Family support and connection are key to helping patients impacted by health challenges. When equipped with more information about cardiovascular diseases such as hyperlipudemia, family members can help patients take action to prevent health risk and overcome their condition better.
In the philippines, there over 130,000 deaths related to Cardiovascular diseases in 2016. CVD is a complex dieases with many risk factors that affects how it develops. One such risk is dyslipidemia, which occurs when one has abnormal levels of lipids in the blood. Lipids, or fats, are essential in providing energy to the cells while cholesterol is vital in the production of hormones and bile acids for healthy digestion.
There are two kinds of cholesterol in the body: "Bad" cholesterol and "good" cholesterol. Elevated bad cholesterol, also knwon as low-density lipoprotein (LDC-C), in the blood increases a person's risk of developing atherosclerotic plaque depositQs which can block the arteries and lead to a heart attack or stroke. Lowering LDL-C also lowers a person's chances of developing CVD.
The standard treatment for lowering LDL-C are statins, but there are cases when statins are not enough. Having acces to new and innovative treatments in the management of dyslipidemia can make a difference for patients who are not able to achive their lipid goals with statin alone.
With the patient at the heart of what we do, Amgen Philippines Inc. and Zuellig Pharma Corporation are commited to improving the lives of patients struggling with dyslipidemia by helping them and their families to take the necessary action to prevent and manage their health risks.
No comments:
Post a Comment